The data demonstrated that miR-223 supplementation could mitigate DSS-driven colonic inflammation by dampening pro-inflammatory pathways while enhancing IL-10-mediated resolution, further supporting its therapeutic potential in colitis. The gene discussed is IL10; the disease is colitis.